Education
About Us
Working with TipRanks
Follow Us
Cronos Group (US) (CRON)
:CRON
CRON Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.60 - $2.77
Previous Close$2.02
Volume2.24M
Average Volume (3M)2.53M
Market Cap
$949.28M
Enterprise Value-$64.79M
Total Cash (Recent Filing)$837.82M
Total Debt (Recent Filing)$1.82M
Price to Earnings (P/E)50.9
Beta0.88
Next Earnings
Nov 05, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.10
Shares Outstanding382,939,580
10 Day Avg. Volume4,736,017
30 Day Avg. Volume2,526,062
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap-0.07
Enterprise Value/Revenue-0.52
Enterprise Value/Gross Profit-1.88
Enterprise Value/Ebitda1.67
Forecast
1Y Price Target
$2.88Price Target Upside12.50% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Bulls Say, Bears Say
Bulls Say
Financial HealthCronos Group has robust liquidity and an asset-light model which supports its operations.
Sales GrowthGrowth was strong in multiple markets, including a 57% increase in Israel and 183% in other countries.
Bears Say
Profitability UncertaintyThe timing of profitability is unclear, and the company is not expected to achieve positive adjusted EBITDA before 2026.
Regulatory ChallengesRegulatory challenges, including unclear US federal cannabis reform and changes to the Canadian Cannabis Act, are significant factors that negatively impact the stock's valuation.
Valuation PressureCronos Group's enterprise value is slightly negative, attributed to the lack of US reform and investor restrictions, which pressures the stock compared to its peers.
Cronos Group News
CRON FAQ
What was Cronos Group (US)’s price range in the past 12 months?
Cronos Group (US) lowest stock price was $1.60 and its highest was $2.77 in the past 12 months.
What is Cronos Group (US)’s market cap?
Cronos Group (US)’s market cap is $949.28M.
When is Cronos Group (US)’s upcoming earnings report date?
Cronos Group (US)’s upcoming earnings report date is Nov 05, 2025 which is in 73 days.
How were Cronos Group (US)’s earnings last quarter?
Cronos Group (US) released its earnings results on Aug 07, 2025. The company reported -$0.1 earnings per share for the quarter, the consensus estimate of -$0.1 by $0.
Is Cronos Group (US) overvalued?
According to Wall Street analysts Cronos Group (US)’s price is currently Undervalued.
Does Cronos Group (US) pay dividends?
Cronos Group (US) does not currently pay dividends.
What is Cronos Group (US)’s EPS estimate?
Cronos Group (US)’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Cronos Group (US) have?
Cronos Group (US) has 382,939,580 shares outstanding.
What happened to Cronos Group (US)’s price movement after its last earnings report?
Cronos Group (US) reported an EPS of -$0.1 in its last earnings report, expectations of -$0.1. Following the earnings report the stock price went up 8.095%.
Which hedge fund is a major shareholder of Cronos Group (US)?
Currently, no hedge funds are holding shares in CRON
Cronos Group Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$2.88 (12.50% Upside)
$2.88 (12.50% Upside)
Blogger Sentiment
Neutral
CRON Sentiment 50%
Sector Average 71%
Sector Average 71%
Crowd Wisdom
Very Positive
Last 7 Days ▼ 2.3%
Last 30 Days ▲ 1.0%
Last 30 Days ▲ 1.0%
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
7.11%
12-Months-Change
Fundamentals
Return on Equity
1.73%
Trailing 12-Months
Asset Growth
7.72%
Trailing 12-Months
Company Description
Cronos Group (US)
Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones and Happy Dance brands in the United States. The company is also involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. It sells cannabis and cannabis products, including dried cannabis, pre-rolls, edibles, concentrates, and cannabis extracts through wholesale and direct-to-client channels under its wellness platform, PEACE NATURALS; and operates under adult-use brands, Spinach. It also exports dried cannabis and cannabis oils to Germany, Israel, and Australia. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.
CRON Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted strong revenue growth and improved gross margins, driven by international expansion and robust market positioning in Canada. However, challenges with flower supply constraints and limited growth in the Canadian market were noted. Overall, the positive aspects significantly outweigh the negative, indicating a strong performance for the quarter.View all CRON earnings summariesCRON Stock 12 Month Forecast
Average Price Target
$2.88
▲(12.50% Upside)
Technical Analysis
Ownership Overview
4.11% Insiders
0.60% Mutual Funds
― Other Institutional Investors
92.55% Public Companies and
Individual Investors